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Breast cancer survivors may experience long-term treatment complications, must live with the risk of
cancer recurrence, and often experience psychosocial complications that require supportive care ser-
vices. In low- and middle-income settings, supportive care services are frequently limited, and program
development for survivorship care and long-term follow-up has not been well addressed.
As part of the 5th Breast Health Global Initiative (BHGI) Global Summit, an expert panel identiﬁed nine
key resources recommended for appropriate survivorship care, and developed resource-stratiﬁed rec-
ommendations to illustrate how health systems can provide supportive care services for breast cancer
survivors after curative treatment, using available resources.
Key recommendations include health professional education that focuses on the management of
physical and psychosocial long-term treatment complications. Patient education can help survivors
transition from a provider-intense cancer treatment program to a post-treatment provider partnership
and self-management program, and should include: education on recognizing disease recurrence or
metastases; management of treatment-related sequelae, and psychosocial complications; and the
importance of maintaining a healthy lifestyle. Increasing community awareness of survivorship issues
was also identiﬁed as an important part of supportive care programs. Other recommendations include
screening and management of psychosocial distress; management of long-term treatment-related
complications including lymphedema, fatigue, insomnia, pain, and women’s health issues; and moni-
toring survivors for recurrences or development of second primary malignancies. Where possible, breast
cancer survivors should implement healthy lifestyle modiﬁcations, including physical activity, and
maintain a healthy weight. Health professionals should provide well-documented patient care records
that can follow a patient as they transition from active treatment to follow-up care.
 2013 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).Global Health Medicine, Department of Surgery, 1959 NE Paciﬁc St, BB437A-Bx 356410, Seattle, WA 98195-6410, USA.
n).
Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
P.A. Ganz et al. / The Breast 22 (2013) 606e615 607Breast cancer survivors in low- and middle-income countries developed by the Breast Health Global Initiative (BHGI) for theTable 1
Resource allocation levels: basic, limited, enhanced, and maximal.
Resource Allocation
Level*
Description
Basic Core resources or fundamental services
absolutely necessary for any breast health
care system to function; basic-level services
are typically applied in a single clinical interaction.
Limited Second-tier resources or services that are
intended to produce major improvements in
outcome, and are attainable with limited
ﬁnancial means and modest infrastructure;
limited-level services may involve single or
multiple clinical interactions.
Enhanced Third-tier resources or services that are optional
but important; enhanced-level resources should
produce further improvements in outcome and
increase the number and quality of therapeutic
options and patient choice.
Maximal High-level resources or services that may be
used in some high-income countries, and/or may
be recommended by breast care guidelines that do
not adapt to resource constraints. They should be
considered lower priority than those resources
or services listed in the basic, limited, or enhanced
categories on the basis of extreme cost and/or
impracticality for broad use in resource-limited
environments; to be useful, maximal-level
resources typically depend on the existence and
functionality of all lower-level resources.
* The table stratiﬁcation scheme implies incrementally increasing resource alloca-
tion at the basic, limited, and enhanced levels. Maximal-level resources should not
be targeted for implementation in LMICs, even though they may be used in some
higher-resource settings.Globally, breast cancer 5-year relative survival rates range
from 80 to 90% in high-income countries (HICs), to 60% in
middle-income countries, to below 40% in low-income countries
[1]; in parts of Africa, it may be as low as 12% [2]. These differ-
ences have been attributed to disparities in early detection, type
of breast cancer, access to treatment, type of treatment, and so-
cial and cultural barriers. The concept of cancer survivorship it-
self as a distinct phase of cancer treatment is relatively new, and
awareness of long-term issues affecting cancer survivors is low,
especially in low- and middle-income countries (LMICs). Breast
cancer patients in LMICs are often younger, and have more
advanced and aggressive disease [3]. Radiotherapy for breast
conservation and sentinel lymph node biopsy for minimally
invasive axillary staging are often unavailable in LMICs [4],
leading to more extensive surgical approaches such as mastec-
tomy and axillary lymph node dissection. These are associated
with higher rates of long-term complications (body image
changes, and loss of arm mobility and lymphedema, respec-
tively). Breast cancer survivors in LMICs may experience greater
effects from chemotherapy-induced early menopause, infertility,
and impairments in sexual function and body image, and may
have an increased risk of recurrence as well as a sense of isola-
tion due to social and cultural conditions. Unfortunately, sup-
portive care services are frequently limited in LMICs; program
development for survivorship care and long-term follow-up
appropriate for LMICs has not been well addressed.
Supportive care after curative treatment (survivorship care)
Supportive care for breast cancer, including survivorship care,
is a distinct aspect of cancer treatment that should be integrated
into breast cancer care programs in low- and middle-income
countries (LMICs). The Institute of Medicine (IOM) describes
survivorship care as encompassing ﬁve main areas: 1) surveil-
lance for cancer recurrence or new cancers; 2) management of
symptoms that persist after treatment ends; 3) evaluation of risk
for, and when possible, prevention of, late-effects of treatment;
4) assessment of psychosocial needs and provision of appro-
priate support; and 5) counseling of patients on lifestyle modi-
ﬁcations for prevention of cancererelated morbidity and
mortality, as well as to improve quality of life [5]. As the inci-
dence of breast cancer increases in LMICs, so too will the number
of breast cancer survivors, as a result of increased efforts
to improve early detection of breast cancer, an increase in
breast cancer care programs, and greater availability of effective
treatments.
Deﬁning “breast cancer survivors”
For the purposes of this consensus statement, “breast cancer
survivors” are deﬁned as patients who have entered the post-
treatment phase after initial surgery, with or without chemo-
therapy and/or radiation (ie, 6 months of curative treatment).
Companion Breast Health Global Initiative (BHGI) supportive care
consensus statements cover supportive care during treatment, and
supportive and palliative care for metastatic disease.
BHGI global summit and expert panel consensus process
All three BHGI supportive care consensus statements provide
recommendations for breast cancer supportive care program
implementation in low- and middle-income settings. Methodsstructured creation of evidence-based, 4-tier resource-stratiﬁed
guidelines and consensus statements (see Table 1) have been pre-
viously described [6,7]. A systematic literature review was per-
formed in preparation for the 5th BHGI Global Summit, which was
held in association with the International Atomic Energy Associa-
tion (IAEA) in Vienna, Austria, on October 2, 2012. Supportive care
was chosen as a theme for the global summit, as it emphasizes
often-overlooked aspects of medical care, which are not always
considered directly related to curative intent. The Supportive Care
after Curative Treatment (Survivorship Care) Consensus Panel
presented on key topics and then performed a consensus analysis
through facilitated expert panel discussion in order to draft the core
resource-stratiﬁed table matrices, which are the primary outcome
of the panel examination and deliberation. Companion consensus
statements for Supportive Care during Treatment [8] and Supportive
and Palliative Care for Metastatic Breast Cancer [9] were developed
in parallel during this 2012 Global Summit. Cancer supportive care
is an under-researched area of medicine, especially in LMICs. Sys-
tematic reviews andmeta-analyses are often not available for select
topics, or include only studies from HICs. When studies from LMICs
are available on a topic, they are provided as additional references.Key resources needed for survivorship supportive care programs
This section of the consensus statement describes the nine key
resources identiﬁed for basic breast cancer supportive care after
curative treatment (survivorship). A resource-stratiﬁed recom-
mendation follows the description of each key resource category,
and is also presented in one of the two tables. The resource-
stratiﬁed tables illustrate how, even at a basic level of resources, a
Table 2
Health systems: health education, community awareness. psychosocial patient-support after curative treatment.
Basic Limited Enhanced Maximal
Health professional
educationa
BCr recurrence, second
primary cancer
Long-term TX complications
Women’s health
Psychosocial (survivorship)
considerationc
Lifestyle modiﬁcations
Psychosocial risk assessments
Psychosocial complications
of survivorship
Sexual health
Psychosocial screening methods
Patient and
family educationb
BCr recurrence or new
cancers; symptoms to report
Long-term TX complications
Appropriate use of CAM
Women’s health issues
Psychosocial issues (survivorship)
Lifestyle modiﬁcations
Follow-up schedules
Adherence to endocrine therapy
Sexual health
Community
awareness
Community awareness of
BCr survivorship issues
Psychosocial
(survivorship)
Patient and family educationb
Psychosocial (survivorship)
considerationc
Peer support by trained
BCr survivors
Psychosocial assessments,
including depression
Emotional and social support
by health professionals
Screening and referral for
depression/distress by
mental health specialist
Psychosocial counseling by mental
health specialists
Availability of pharmacotherapy
Social service counseling for ﬁnancial,
employment and legal issues
Psychiatrist-, psychologist-,
or social worker-coordinated
care
Note: The table stratiﬁcation scheme implies incrementally increasing resource allocation at the basic, limited, and enhanced levels. Maximal-level resources should not be
targeted for implementation in LMICs, even though they may be used in some higher-resource settings.
Abbreviations: BCr, breast cancer; CAM, complementary and alternative medicine; TX, treatment.
a The term “health professional” is used to acknowledge the range in medical and other professionals who provide supportive care services in LMICs. When specialists are
identiﬁed as a required resource, it is assumed that a specialist has a certiﬁcation for their area of expertise.
b Patient, family and/or partner education may be the primary intervention for some supportive care services.
c “Consideration” is a term used in this table to refer to basic patient evaluation through patient-provider interactions, including dialogue, observations, and other
appropriate means of evaluation.
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to breast cancer survivors, and plan for incremental program im-
provements. If a topic is covered in more detail in another com-
panion consensus statement, a link and reference is provided.
Health systems (Table 2)
Health professional education (Table 2, row 1)
Description. Breast cancer supportive care programs are
emerging as distinct, specialized ﬁelds of medicine that require
cross-disciplinary health professional education [10]. The term
“health professional” is used to acknowledge the range of medical
and other professionals who provide supportive care services in
LMICs. When specialists are identiﬁed in a recommendation as a
required resource, it is assumed that the specialist has a certiﬁcation
for their area of expertise.
Health professional education should address surveillance for
breast cancer recurrence and second primary cancers, including
patient characteristics and other risk assessments. It should
include monitoring for and management of long-term treatment
complications, including lymphedema, fatigue, insomnia, and
pain, as well as symptom management for long-term treatment-
related women’s health issues (eg, hormone, menopausal symp-
toms, sexual health issues). In addition, health professional
education should include awareness about the psychosocial
complications of survivorship, including depression, emotional
distress and changes to social roles, and should include informa-
tion about available patient support services to manage psycho-
social problems. Health professionals should also be instructed
about how to educate patients regarding lifestyle modiﬁcations
that may reduce cancer risks and improve quality of life. Healthprofessionals should be educated about health literacy and cul-
tural sensitivity. (See the companion BHGI consensus statement,
Supportive Care during Treatment [8], for a more detailed discus-
sion on cultural sensitivity).
1. Panel recommendations. At basic levels of resource alloca-
tion, health professional education should include education
about breast cancer recurrence and second primary cancers, and
recognition and management of physical/clinical complications of
long-term treatment, including women’s health issues (eg,
reproductive health, early menopausal symptoms, body image). It
should include awareness and recognition of psychosocial com-
plications of treatment, and lifestyle modiﬁcations to reduce
cancer risk and improve quality of life. At limited levels, health
professional education should include awareness of patient
characteristics associated with increased risk for depression,
anxiety or distress, and long-term psychosocial complications.
Education should include sexual health issues. At enhanced
levels, health professional education should include methods for
psychosocial screening.
Patient and family education (Table 2, row 2)
Description. Clear and open communication between a patient,
their family, and health professionals is an important part of breast
cancer supportive care [11]. Patient education can help survivors
transition from a provider-intense cancer treatment program to an
after-treatment provider partnership and self-management pro-
gram. Survivorship patient education should help patients and
their families understand how to recognize the signs and symp-
toms of disease recurrence or metastases (eg, cough, shortness of
breath, abdominal discomfort, loss of appetite and weight loss)
Table 3
Survivorship issues: long-term complications, lifestyle modiﬁcations, monitoring and documentation following curative treatment.
Basic Limited Enhanced Maximal
Long-term treatment-related
complications
Patient and family educationb on
long-term TX complications
Antibiotics for cellulitis
or lymphangitis
Basic lymphedema supplies
PT, OT, CDT for lymphedema
management
Fatigue, insomnia management
Pain management
Coordinated care by
oncology-trained
personnel/nursing staff
Custom compression garments
Pneumatic pump
Perometer
Women’s healtha Patient and family educationb on
early menopause, body image
Patient and family educationb
on sexual health
TX of menopausal symptoms:
topical agents and simple
behavioral strategies
Pharmacotherapy for
menopausal symptoms
Breast reconstruction
for asymmetry
Bone-modifying agents
Clinical assessment and
tailored intervention for
menopausal symptoms
and sexual health
Lifestyle modiﬁcation Patient educationb on
diet and exercise
Weight management and
daily exercise counseling
Exercise program
Individualized education
by dietitian
Weight management program
Monitoring Monitor for BCr recurrence,
second primary cancers
Monitor for long-term
TX complications
Monitor for endocrine
medication adherence
Genetic testing and counseling
Screening for high-risk cancers
Documentation Patient care record
(eg, discharge summary)
Patient treatment summary Survivorship care plan
Note: The table stratiﬁcation scheme implies incrementally increasing resource allocation at the basic, limited, and enhanced levels. Maximal-level resources should not be
targeted for implementation in LMICs, even though they may be used in some higher-resource settings.
Abbreviations: BCr, breast cancer; CDT, complete-decongestive therapy; PT, physiotherapy, OT, occupational therapy, TX, treatment.
a Women’s health issues for breast cancer patients include menopause, reproductive health, fertility, body image, and sexual health; educational efforts should include
partners, as appropriate.
b Patient, family and/or partner education may be the primary intervention for some supportive care services.
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adhering to longer-term endocrine therapy, if prescribed. Educa-
tion on the management of treatment sequelae, including lym-
phedema, fatigue and insomnia [8], and pain [9], should be
provided. Women’s health issues should be addressed, including
menopausal symptoms, body image, and sexual health complica-
tions. (Reproductive health and fertility concerns are discussed in
the companion BHGI consensus statement, Supportive Care during
Treatment [8]). Partners should be included in sexual health edu-
cation, when appropriate. Psychosocial complications (eg, depres-
sion and emotional distress) and social issues (eg, changing roles at
home and work) are important components of supportive care
programs that are often overlooked, especially if more intense or
urgent physical complications dominate. Healthy lifestyle modiﬁ-
cations should be part of survivorship educational programs. For
example, remaining physically active, as tolerated, is recom-
mended during treatment [8], and its importance should be rein-
forced post-treatment, as needed. Guidelines on nutrition and
exercise developed in HICs can be adapted, as appropriate, to a
particular country or area. Cultural sensitivity and health literacy
should be considered when communicating with patients at all
levels of resource allocations. Breast cancer educational strategies
should be culturally sensitive and appropriate [13e17]. (See the
companion BHGI consensus statement, Supportive Care during
Treatment [8], for a discussion on cultural sensitivity.)
2. Panel recommendations. At basic levels of resource allocation,
patient and family education should include discussions on breast
cancer recurrence and second primary cancers and symptoms to
report. Patient and family education should include discussions on
persistent or late-effects of treatment (eg, lymphedema, fatigue,
insomnia, pain), symptoms to report, and management strategies,
including the appropriate use of complementary and alternative
medicine. Women’s health issues (early menopause, body image),
and psychosocial problems (eg, depression, emotional distress, and
changing roles at home and work), and lifestyle modiﬁcations (eg,diet and exercise), should be included. At limited levels, education
should include the importance of follow-up scheduling, adherence
to endocrine therapy, and sexual health issues. Patient and family
education should be culturally appropriate; partners should be
included, as appropriate.
Community awareness (Table 2, row 3)
Description. In LMICs, community education campaigns have
successfully raised awarenessof breast cancer and the importance of
early detection [18]. Similar efforts are needed to educate commu-
nities about breast cancer supportive care programs, including
survivorship programs [19]. Education of patients, families, and the
community has been shown to address and minimize women’s
potential ambivalence in prioritizing their health, and their fears of
diminished femininity and partner’s rejection [20e22]. Breast can-
cer survivorship awareness/outreach should be a component of
breast cancer supportive care programs, and should be socially and
culturally sensitive [23]. Community advocates can help raise
awareness of breast cancer survivorship issues. Programs used
successfully to improve awareness of the importance of breast
cancer early detection could be adapted to breast cancer survivor
awareness efforts. Partnerships with successful community-based
public health awareness programs, such as those for HIV, could be
considered.
3. Panel recommendations. At basic levels of resource allocation,
breast cancer supportive care should include outreach to the com-
munity to increase awareness of breast cancer survivorship issues,
by working with community advocates and advocacy organizations.
Psychosocial aspects of survivorship (Table 2, row 4)
Description. Psychosocial complications of survivorship are
often not addressed, despite reports of depression and distress
among breast cancer patients. In LMICs, reports of depressive
symptoms among breast cancer patients range from 8 to 60% based
on studies from Turkey and Greece [24e26], Korea [27], Portugal
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Reports from LMICs on anxiety disorders range from 12 to 60% [24e
26,28,30]. Screening for and treatment of depression and anxiety
may improve quality of life for breast cancer survivors [32].
Depression screening tools developed in HICs have been adapted
for use in many LMICs, and include the Hospital Anxiety and
Depression Scale (HADS) [25,27,33], the Beck Depression Inventory
(BDI) [26,34], and a simpliﬁed depressed mood thermometer [28].
Several study outcomes in LMICs suggest that the process of
screening for, and identiﬁcation of depression can reveal associated
psychosocial issues [26,29,34e36]. Social disruption, including
changing roles at home and work, can lead to psychosocial com-
plications. Treatment for psychosocial problems ranges from peer
support to coordinated therapy by psychiatrist or psychologists.
4. Panel recommendations. At basic levels of resource allocation,
health professionals should consider (through observation, dia-
logue, and other appropriate means) psychosocial problems of
breast cancer survivors, and refer patients to peer support by
trained peer volunteers, as appropriate. Patient and family educa-
tion regarding survivorship issues should be offered. At limited
levels, psychosocial assessment, including assessment for depres-
sion, should be available, with referrals for emotional and social
support as indicated. At enhanced levels, patients should be
screened for depression and psychological distress by mental
health specialists and referred for psychosocial counseling as
appropriate. Pharmacotherapy for depression and distress, based
on available research and clinical practice guidelines (CPGs), should
be available. Social services, including employment, ﬁnancial, and
legal counseling, should be available. At maximal levels, coordi-
nated mental health care by a psychiatrist, psychologist, or social
workers could be considered.
Survivorship issues (Table 3)
Long-term treatment-related complications (Table 3, row 1)
Description. Long-term treatment-related physical/clinical
complications include lymphedema, fatigue, insomnia, and pain.
Managing lymphedema and shoulder morbidity can be a major
concern for breast cancer survivors in LMICs. Patients should be
encouraged to self-report upper extremity limb changes. Moni-
toring for lymphedema can be done using basic circumferential
measurements of limb girth (www.armvolume.com) [37], and
bioelectric impedance devices [38]. More advanced monitoring
strategies, such as perometers, can add sensitivity to limb girth
measurement and promote early identiﬁcation of limb asymmetry
[39]. Patient and family education should include teaching simple
shoulder movement exercises, and how to incorporate these ex-
ercises into daily activities. Limb compression supplies, such as
non-custom sleeves [39] or stretch tubing, are often available and
may be helpful in controlling lymphedema, whereas physical
therapy (PT) or occupational therapy (OT), including the more
intense lymphedema treatment of complex-decongestive therapy
(CDT), will require signiﬁcant expertise to provide. Early intro-
duction of lymphedema therapy, including arm exercises and
lymphatic massage, has been associated with a lower incidence of
lymphedema, compared to controls [40]. Resistance exercise may
reduce symptom exacerbations in survivors with lymphedema
[41]. A study in Australia found that women who are informed
and knowledgeable about lymphedema risk and management
were more likely to adhere to recommended patient-directed
lymphedema prevention and management strategies [42]. Pa-
tient education should also include self-management for other
late-effects of treatment, including fatigue, insomnia and pain.
(See the BHGI companion consensus statement, Supportive Care
during Treatment [8], which covers fatigue, insomnia and pain
complications during treatment [8]).5. Panel recommendations. At basic levels of resource allocation,
patient and family education about symptom management should
be provided. Antibiotics should be available for treating cellulitis or
lymphangitis. Basic lymphedema supplies (eg, non-custom sleeves
or stretch tubing) should be available to ensure that patients can
participate in at-home lymphedema care. At limited levels, phys-
ical therapy (PT) and occupational therapy (OT), including
complete-decongestive therapy (CDT) for lymphedema manage-
ment should be available. Continued support for symptoms of fa-
tigue, insomnia, and pain should be provided [8]. At enhanced
levels, custom compression garments should be available. Coordi-
nated care by oncology-trained personnel, such as nursing staff,
should be available. At maximal levels, pneumatic pumps and
perometers (infrared measuring device) could be considered.
Women’s health issues (Table 3, row 2)
Description. Breast cancer survivors have unique women’s
health issues with regards to early menopause, body image, and
sexual health. Early menopausal symptoms can be a major long-
term treatment effect in LMICs where the majority of women
receiving chemotherapy are premenopausal. Health professionals
should be able to predict a patient’s risk of developing early
menopause, based on factors such as patient age, and the type and
duration of treatments received; health professionals and patients
should be able to recognize symptoms of earlymenopause [43e45].
Interventions for managing menopausal symptoms include non-
hormonal topical treatments for vaginal dryness and behavioral
strategies for managing hot ﬂashes. These efforts are especially
important for breast cancer care in low-resource settings. Health
professionals in LMICs should be aware of sociocultural factors that
can inﬂuence a woman’s knowledge and understanding of meno-
pause [46]. A LMIC study concluded that premenopausal women
with breast cancer received insufﬁcient counseling on contracep-
tion, early menopause, infertility, fertility preservation, and
sexuality [47]. Several studies in HICs have reported that premen-
opausal women receive insufﬁcient counseling on those issues,
despite their interest in receiving such information [47e49]. Clin-
ical assessments and tailored intervention programs for meno-
pausal symptommanagement have been demonstrated, in HICs, to
reduce symptom burden and improve sexual functioning [50]. (See
the companion BHGI consensus statement, Supportive Care during
Treatment [8], for recommendations and discussion on fertility).
Declines in sexual satisfaction and/or the frequency of inter-
course have been reported in LMICs after breast cancer treatment
[51e53]. Efforts are ongoing to identify the best educational in-
terventions for sexual health [54]. Studies in LMICs have reported
women’s distress regarding body (breast) changes [51,52,55].
Concerns about body image include feelings of being mutilated,
leading to feelings of self-consciousness; reduced satisfaction with
sexual life after treatment; and fears of partner rejection [52]. Body
image problems can occur with both mastectomy and breast-
conserving therapy [51,52]. A study of South Asian breast cancer
survivors in Canada identiﬁed body image as an important psy-
chosocial issue when wearing ethnic outﬁts that outlined the fe-
male ﬁgure [56]. Health professionals in all settings need to include
culturally appropriate information on sexual health in patient-
centered interactions with breast cancer survivors, with compan-
ion information for sexual partners. “Sexual health” is deﬁned by
the World Health Organization (WHO) as “a state of physical,
emotional, mental and social well-being in relation to sexuality; it
is not merely the absence of disease, dysfunction or inﬁrmity” [57].
6. Panel recommendations. At basic levels of resource allocation,
patient and family education on women’s health issues (eg, early
menopause and body image) should be available. At limited levels,
treatment of menopausal symptoms with behavioral strategies (eg,
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agents (eg, non-hormonal vaginal moisturizers) is recommended.
Patient and partner education on sexual health should be available.
At enhanced levels, pharmacotherapy to manage menopausal
symptoms should be available, and could include antidepressants
and complementary therapies; these should be administered based
on clinical practice guidelines and available research. Breast
reconstruction for asymmetry to address body image concerns
should be provided, as needed. Bone-modifying agents (eg,
bisphosphonates) should be available for women who may be at
increased risk for osteopenia and osteoporosis due to premature
menopause. At maximal levels, clinical assessment and tailored
interventions to reduce menopausal symptoms and improve sexual
function could be considered.
Lifestyle modiﬁcations (Table 3, row 3)
Description. Observational studies in HICs suggest that women
who are physically active [58] and maintain a normal weight [59]
have lower risk for breast-cancer-speciﬁc death and for death
fromany cause. Guidelines for optimal lifestyles for cancer survivors
in HICs, on topics such as physical activity [60] and nutrition [61],
can be adapted to LMIC settings. They should be tailored tomeet the
physical limitations and comorbid conditions of an individual pa-
tient, and should be socially, culturally and economically appro-
priate. For example, strategies to modify ethnically speciﬁc foods
and make incremental changes in diet should be encouraged.
Strategies for optimal nutrition to avoid obesity and weight gain
include diets low in fat and reﬁned sugars, and high in ﬁber, vege-
tables and fruits. A randomized controlled trial (RCT) of 2437
womenwith breast cancer found that a low-fat diet reduced risk for
recurrence or second primary breast cancer by 24% over a mean 60
months of follow-up [62], whereas another RCT that focused on
fruits and vegetables found no effect [63]. A systematic review
found that physical activity is associated with reduced breast-
cancer-speciﬁc and all-cause mortality [58]. Resistive exercise may
reduce symptoms of lymphedema [41]. RCTs have shown that short-
term structured aerobic exercise programs may improve quality of
life in breast cancer survivors [60]. Recommended physical activity
(eg, 150 min/week of moderate-to-vigorous physical activity, and
resistance exercise at least twice a week) can be modiﬁed to
accommodate community and cultural habits, and conducted in-
dependent of the health care system (eg, at home, with relatives or
friends, or in the community). General lifestyle recommendations
for breast cancer survivors should follow general healthy living
advice associated with chronic disease prevention, as breast cancer
survivors are susceptible to chronic diseases (eg, cardiovascular
disease), and often die from them. Disease prevention aspects of
care should not be ignored due to a history of cancer [64].
7. Panel recommendations. At basic levels of resource allocation,
patient education should include the associations between lifestyle
factors and breast health, and the importance of nutrition and ex-
ercise. At limited levels, counseling on the importance of weight
management (overweight, underweight) and regular exercise on
most days of theweek should be offered. At enhanced levels, formal
exercise programs and individualized education or counseling by a
dietitian should be offered. At maximal levels, speciﬁc weight
management programs could be offered.
Monitoring (Table 3, row 4)
Description. Follow-up care of patients after completion of
initial treatment is needed to monitor for possible recurrences,
long-term side effects of treatments [12], and development of
second primary malignancies (eg, breast, cervical, ovarian, and
colon) [65], and to optimize overall physical and emotional health
[65,66]. Follow-up frequency and intensity should reﬂectunderlying patient risk factors [12,66]. Intervals between visits,
length of follow-up period, providers responsible for follow-up, and
investigations performed at each follow-up visit should be based on
individual patient proﬁles [67]. However, the expert panel agreed
that a review of systems and physical examination would likely
detect the majority of recurrences; routine blood and radiologic
studies are not recommended, as they have not been proven to have
an impact on survival. Monitoring and follow-up care should be
patient-speciﬁc [67], and provide patients with information about
those responsible for their post-treatment care [68]. Women with
ER-positive breast cancer should be monitored for adherence to
endocrine therapy, because side effects (vaginal discharge,
arthralgia and hot ﬂashes) may cause women to stop using the
medication, in the absence of reinforcement and/or non-hormonal
supportive care interventions [69].
8. Panel recommendations. At basic levels of resource allocation,
monitoring for cancer recurrence or second primary cancers with
review of systems and physical examination should be part of
follow-up care. At limited levels, monitoring for adherence to
endocrine therapy should be provided. At maximal levels, genetic
counseling and screening for high-risk cancers should be considered.
Documentation (Table 3, row 5)
Description. Breast cancer care is multidisciplinary and thus
requires the use of shared patient care records. As survivors tran-
sition from oncology-focused care to primary care or community-
based care, a detailed diagnosis and treatment summary should
follow the patient, and include primary tumor biology, stage of
disease, and sequence of given treatments. Recent literature re-
views found that many primary care providers did not receive
adequate documentation regarding a patient’s diagnosis and
treatment when the patient transitioned to their care [70,71]. Both
physicians [72] and patients [56,73,74] in HICs have identiﬁed
treatment summaries as helpful and preferred information re-
sources [68]. Simple patient care documentation strategies include
hospital discharge reports or outpatient treatment summaries.
More advanced documentation can include treatment summaries
and survivorship plans.
9. Panel recommendations. At basic levels of resource allocation,
health professionals should provide well-documented patient care
records that can follow a patient as they transition from active
treatment to follow-up care. At limited levels, treatment sum-
maries should be provided to patients to share with their providers.
At enhanced levels, survivorship plans could be considered.
Special concerns and emerging issues in LMICs
Fear of cancer e patient’s own risk assessment
Studies in LMICs have documented breast cancer patients’ fears
and concerns about how the diagnosis of breast cancer, as well as
breast cancer treatments, may impact their lives [20,75]. Breast
cancer patients taking endocrine therapy may have fear of recur-
rence related to extended treatment protocols, though others may
feel protected by extended adjuvant therapy [76]. As more breast
cancer patients in LMICs become survivors, fear of cancer recur-
rence may emerge as an area of concern, especially in younger
survivors. Studies in HICs have documented breast cancer survi-
vors’ fear of cancer recurrence [77,78]. A systematic review found
associations between fear of cancer recurrence and physical
symptoms, treatment type, low optimism, family stressors, and
fewer signiﬁcant persons as support [79]. Other reviews found that
younger breast cancer survivors are more likely to report fear of
recurrence [79], and are more likely to experience more intense
fears [48,80], as well as to report worries about health, social roles,
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determine the cutoff for clinically signiﬁcant fear of recurrence [82].
Advanced documentation
Survivorship care plans are formal documents that include:
scheduled follow-up visits; documentation of required in-
vestigations, such as yearly mammograms; and information about
who will be responsible for these aspects of post-treatment care
[68]. Based on recommendations from the Institute of Medicine
(IOM) [5], survivorship plans are being evaluated as a tool to help
patients and providers communicate and track follow-up care and
concerns. Two studies provide models for how survivorship care
plans can be adapted for LMICs, including plans to helpmanage late-
effects of treatment and promote healthy living [68], and to deﬁne
patient preference for content and format of survivorship care plans
based on patient demographics [73]. A review article provides de-
tails on implementing treatment summaries as part of survivorship
plans [68]. Templates of treatment summaries are available on the
ASCOwebsite (www.asco.org), and have been adapted for electronic
use by Journey Forward (www.journeyforward.org). Finding a brief
and concise format for survivorship plans is needed for imple-
mentation in low-resource settings.
Advanced lymphedema care
In cases where more pronounced functional loss or pain asso-
ciated with lymphedema requires additional rehabilitation medi-
cine expertise or care coordination, consultation with a physiatrist
can be helpful to assist with medical management of lymphedema
(as well as other physical or cognitive impairments), and provides
an interdisciplinary approach to coordination of care. Pneumatic
compression pumps, recommended only at a maximal level of
resource allocation, are relatively expensive and may not be effec-
tive when used as an isolated treatment [83]. More research is
needed regarding advance treatments; other advance treatments
include laser therapy [84], kinesiotaping [85], and liposuction [86].
Cardiotoxicity
Adjuvant chemotherapy and/or radiation therapy, as well as
HER2/neu targeted therapies, may cause late cardiotoxicity (eg,
cardiomyopathy, coronary ischemia, thromboembolism, arrhyth-
mias and conduction abnormalities, and valvular and pericardial
disease) in up to 33% of patients [87]. Pre-existing cardiovascular
conditions may compound adverse effects of cardiotoxic treat-
ments. There are no current guidelines to address ongoing cardiac
surveillance for breast cancer patients, but it has been the subject of
a recent review [87]. (See the companion BHGI consensus state-
ment, Supportive Care during Treatment [8], which covers
treatment-related toxicities.)
Sexual health
Health systems should acknowledge sexual health as a valid
health indicator. Awareness of the incidence of sexual health issues,
and the associated causes of sexual dysfunction, should be part of
health professional education. Reports from LMICs of declines in
sexual satisfaction and/or the frequency of intercourse range from
20% to 80% [51e53]. LMIC studies also indicate that low sexual
desire and dyspareunia are common symptoms experienced by
breast cancer patients [51,52,55]. Reasons for disturbed sexual
functionmay include low self-esteem, hair loss, abrupt menopause,
vaginal dryness, partner’s difﬁculty understanding one’s feelings,
and body image problems [88e90]. Upper limb dysfunction (eg, asa result of lymphedema) may interfere with sexual functioning
[91]. Discussions of sexual health may be taboo in some cultures
[92]; however, it is important for health professionals to
acknowledge and discuss a patient’s sexual health concerns. Health
professionals should be prepared to discuss: body changes after
surgery; chemotherapy-induced menopausal changes and strate-
gies to maintain vaginal health (eg, use of vaginal moisturizers and
lubricants, pelvic ﬂoor exercises); and reduced sexual desire that
may occur during treatment and the ﬁrst year of recovery [93].
Psycho-educational interventions for sexual dysfunction include
skill-based training (such as problem-solving), communication
skills, counseling, hypnosis, and speciﬁc sex therapies delivered to
individual patients, patients and their partners, and groups of pa-
tients [94]. Interventions shown to produce stronger effects tend to
be couple-focused, and include treatment components that: 1)
educate both partners about the woman’s diagnosis and treat-
ments; 2) promote couples’ mutual coping and support processes;
and 3) include speciﬁc sexual therapy techniques to address sexual
and body image concerns [93].
Depression and distress screening
Screening for depression and emotional distress is a compo-
nent of cancer care guidelines in HICs [95] and some LMICs
[96,97]. (See the companion BHGI consensus statement, Supportive
Care during Treatment [8], for more details.) The expert panel had
mixed opinions regarding the resource allocation level for
screening of depression, with ﬁnal consensus that formal
screening should be required at an enhanced level of resource
allocation. For psychological distress, there does not seem to be
conclusive evidence for the overall effectiveness of screening
methods [98,99]. However, screening does seem to improve
patient-provider communication, and can be a mechanism for
prompting referrals to peer support or to mental health pro-
fessionals. The panel did agreed that consideration of depression
and emotional distress (which can occur as part of patient-
provider interactions and observations) should be part of routine
supportive care at a basic level of resource allocation, and that it is
an area that needs much improvement. For example, a report on
Slovak breast cancer survivors identiﬁed psychosocial support as
an urgent need in this LMIC [100]. A report from Spain concluded
that follow-up care for breast cancer survivors should address
emotional, psychological and/or social effects of treatment
sequelae (eg, effects of lymphedema, early menopause, and
infertility; fear of recurrence; and changes in family relationships
and employment) [101].
Advanced psychosocial interventions
Interventions studied in HICs include educational/informational
programs [102], bio-behavioral programs [103], problem-solving
and behavioral activation [104], mindfulness [105], and supportive
expressive therapies [106]. Adjuvant pharmacotherapy may be
useful for some patients.
Employment and work-related issues
Delays in returning to work are associated with more advanced
disease at diagnosis, axillary lymph node involvement, and HER2/
neu-positive tumors [107]; lack of support from employers [108];
and other medical, demographic and socioeconomic factors [109].
In HICs, 80% of breast cancer patients returned to work [109e111],
although the rate was lower for some subpopulations, such as low-
income Latina women in the USA [110]. Work-related issues in
LMICs have not been well documented.
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Studies on alcohol and tobacco use in HICs may not be directly
translatable to LMICs. Alcohol use in HICs is associated with both
increased risk of primary breast cancer [112] and risk of recurrence
in postmenopausal women [113]; however, the association be-
tween alcohol use and breast cancer prognosis is unclear. Tobacco
use is associated with several diseases for which breast cancer
survivors are at increased risk, such as cardiovascular disease [114];
however, observational studies have not shown a consistent rela-
tionship between tobacco use and survival or recurrence [115].
Genetic testing
US Preventive Task Force guidelines recommend genetic
screening for women at high risk for familial breast cancer syn-
drome [12,44]. In addition to the ﬁnancial burden of testing,
identifying women in LMICs with a genetic predisposition for
breast cancer may carry cultural and social stigmas. The panel
recommended genetic counseling at maximal levels of resource
allocation. However, this does not negate its importance for breast
cancer survivors who have a family history of early onset breast
and/or ovarian cancer, or for those diagnosed at a very young age
without a strong family history. Genetic counseling can provide
opportunities for these women to reduce risks of second cancers.
For example, survivors who test positive for BRCA1/2 may wish to
receive risk-reducing surgery (prophylactic mastectomy, bilateral
salpingo-oophorectomy). Family members may also beneﬁt by
receiving heightened breast cancer surveillance, chemoprevention,
or risk-reducing surgery. Although genetic testing to identify cancer
risk may elevate some patients’ or families’ fears, consideration of
cultural and social acceptance of genetic testing and inheritable
traits is important as it helps inform future health decisions.
Discussion
The most effective way to expand survivorship care in LMICs
is through the involvement of primary care networks and
community-based programs. We hope that by having shared tools,
such as this consensus statement and the resource-stratiﬁed tables,
breast cancer health professionals can engage in a global conver-
sation and encourage efforts to implement and improve supportive
care programs in LMICs for breast cancer survivors.
Recommendations included in this consensus report are part of
the continuum of care that begins with diagnosis, and continues
throughout the remainder of a woman’s life. Survivorship care is
intended to maximize health and well-being, while using tailored
strategies to monitor for recurrence and late-effects of treatments.
Many women will have an uneventful recovery from their treat-
ments, while others may experience serious physical or psycho-
social sequelae. Health professionals and others must be prepared
to educate women and their families about the most common is-
sues they are likely to experience, and to address each woman’s
speciﬁc problems, in order to enhance recovery, improve func-
tioning, and maximize adherence to recommended treatments.
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